200,000+ products from a single source!

sales@angenechem.com

Home > Thiazole > 533-45-9

533-45-9

533-45-9 | Clomethiazole

CAS No: 533-45-9 Catalog No: AG00DE16 MDL No:MFCD00868012

Product Description

Catalog Number:
AG00DE16
Chemical Name:
Clomethiazole
CAS Number:
533-45-9
Molecular Formula:
C6H8ClNS
Molecular Weight:
161.6524
MDL Number:
MFCD00868012
IUPAC Name:
5-(2-chloroethyl)-4-methyl-1,3-thiazole
InChI:
InChI=1S/C6H8ClNS/c1-5-6(2-3-7)9-4-8-5/h4H,2-3H2,1H3
InChI Key:
PCLITLDOTJTVDJ-UHFFFAOYSA-N
SMILES:
Cc1ncsc1CCCl
EC Number:
208-565-7
UNII:
0C5DBZ19HV

Properties

Complexity:
89.1  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
161.007g/mol
Formal Charge:
0
Heavy Atom Count:
9  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
161.647g/mol
Monoisotopic Mass:
161.007g/mol
Rotatable Bond Count:
2  
Topological Polar Surface Area:
41.1A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
2.1  

Literature

Title Journal
Cytochrome P450 inhibition potential of new psychoactive substances of the tryptamine class. Toxicology letters 20160122
Inhibition of cytochrome P4502E1 by chlormethiazole attenuated acute ethanol-induced fatty liver. Chemico-biological interactions 20141005
CMZ reversed chronic ethanol-induced disturbance of PPAR-α possibly by suppressing oxidative stress and PGC-1α acetylation, and activating the MAPK and GSK3β pathway. PloS one 20140101
Design and synthesis of neuroprotective methylthiazoles and modification as NO-chimeras for neurodegenerative therapy. Journal of medicinal chemistry 20120809
Ethanol induction of CYP2A5: role of CYP2E1-ROS-Nrf2 pathway. Toxicological sciences : an official journal of the Society of Toxicology 20120801
Heart rate turbulence during acute alcohol withdrawal syndrome. Drug and alcohol dependence 20120501
Substitution therapy for alcoholism: time for a reappraisal? Journal of psychopharmacology (Oxford, England) 20120201
Association between leptin levels and doses of clomethiazole during alcohol withdrawal: a pilot study. European addiction research 20120101
Anti-Alcohol and Anxiolytic Properties of a New Chemical Entity, GET73. Frontiers in psychiatry 20120101
Dihydrocodeine/Agonists for alcohol dependents. Frontiers in psychiatry 20120101
Antidopaminergic drugs and acute pancreatitis: a population-based study. BMJ open 20120101
Endothelial dysfunction during acute alcohol withdrawal syndrome. Drug and alcohol dependence 20111201
Gender and use of hypnotics or sedatives in old age: a nationwide register-based study. International journal of clinical pharmacy 20111001
Therapeutic drug monitoring for drugs used in the treatment of substance-related disorders: literature review using a therapeutic drug monitoring appropriateness rating scale. Therapeutic drug monitoring 20111001
Sulforaphane prevents microcystin-LR-induced oxidative damage and apoptosis in BALB/c mice. Toxicology and applied pharmacology 20110815
Role of CYP2E1 in ethanol-induced oxidant stress, fatty liver and hepatotoxicity. Digestive diseases (Basel, Switzerland) 20110401
S100B and homocysteine in the acute alcohol withdrawal syndrome. European archives of psychiatry and clinical neuroscience 20110301
Effects of AMPA and clomethiazole on spreading depression cycles in the rat neocortex in vivo. European journal of pharmacology 20110225
Comparison of two oral symptom-triggered pharmacological inpatient treatments of acute alcohol withdrawal: clomethiazole vs. clonazepam. Alcohol and alcoholism (Oxford, Oxfordshire) 20110101
Carbamazepine and valproate as adjuncts in the treatment of alcohol withdrawal syndrome: a retrospective cohort study. Alcohol and alcoholism (Oxford, Oxfordshire) 20110101
[Diagnostics and therapy of alcohol withdrawal syndrome: focus on delirium tremens and withdrawal seizure]. Psychiatrische Praxis 20100901
Impaired cerebral autoregulation during acute alcohol withdrawal. Drug and alcohol dependence 20100801
DNA methylation of the POMC gene promoter is associated with craving in alcohol dependence. Journal of neural transmission (Vienna, Austria : 1996) 20100401
An open trial of gabapentin in acute alcohol withdrawal using an oral loading protocol. Alcohol and alcoholism (Oxford, Oxfordshire) 20100101
Medications acting on the GABA system in the treatment of alcoholic patients. Current pharmaceutical design 20100101
Oxazepam versus clomethiazol in alcohol withdrawal treatment. European addiction research 20100101
Low effective organizational strategies in visual memory performance of unmedicated alcoholics during early abstinence. Psycho-social medicine 20100101
Characterization of cardamonin metabolism by P450 in different species via HPLC-ESI-ion trap and UPLC-ESI-quadrupole mass spectrometry. Acta pharmacologica Sinica 20091001
Oxcarbazepine in combination with Tiaprid in inpatient alcohol-withdrawal--a RCT. Pharmacopsychiatry 20090901
Neurotoxicity of drugs of abuse--the case of methylenedioxyamphetamines (MDMA, ecstasy), and amphetamines. Dialogues in clinical neuroscience 20090901
[Pharmacotherapy of substance dependence and withdrawal syndromes]. Therapeutische Umschau. Revue therapeutique 20090601
Gamma hydroxybutyric acid (GHB) for the treatment of alcohol dependence: a review. International journal of environmental research and public health 20090601
[Anticonvulsants in the treatment of alcoholism]. Fortschritte der Neurologie-Psychiatrie 20090401
Modeling subpopulations with the $MIXTURE subroutine in NONMEM: finding the individual probability of belonging to a subpopulation for the use in model analysis and improved decision making. The AAPS journal 20090301
Severe protracted alcohol withdrawal syndrome: prevalence and pharmacological treatment at an inpatient detoxification unit--a naturalistic study. Pharmacopsychiatry 20090301
Subchronic MK-801 behavioural deficits in rats: partial reversal by the novel nitrate GT 1061. Pharmacology, biochemistry, and behavior 20090201
Gamma-hydroxybutyric acid versus clomethiazole for the treatment of alcohol withdrawal syndrome in a medical intensive care unit: an open, single-center randomized study. The American journal of drug and alcohol abuse 20090101
[Use of combined treatment with melatonin and clomethiazole in circadian rhythm sleep disorder in the elderly with dementia]. Revista espanola de geriatria y gerontologia 20090101
Reduced cardio-respiratory coupling in acute alcohol withdrawal. Drug and alcohol dependence 20081201
[Emergency checklist: delirium tremens]. MMW Fortschritte der Medizin 20081009
Treatment with clomethiazole is associated with lower rates of premature discharge during alcohol withdrawal. Pharmacopsychiatry 20080701
[Pharmacotherapy of alcohol dependence]. MMW Fortschritte der Medizin 20080519
The effectiveness of anticonvulsants in psychiatric disorders. Dialogues in clinical neuroscience 20080301
Association between inflammatory mediators and response to inhaled nitric oxide in a model of endotoxin-induced lung injury. Critical care (London, England) 20080101
A comprehensive functional analysis of tissue specificity of human gene expression. BMC biology 20080101
Pharmacologic neuroprotection: the search continues. The journal of extra-corporeal technology 20071201
Depletion of S-adenosyl-l-methionine with cycloleucine potentiates cytochrome P450 2E1 toxicity in primary rat hepatocytes. Archives of biochemistry and biophysics 20071015
Angiogenesis as a predictive marker of neurological outcome following hypoxia-ischemia. Brain research 20070926
Clinical studies with oral lipid based formulations of poorly soluble compounds. Therapeutics and clinical risk management 20070801
AMPA receptor activation reduces epileptiform activity in the rat neocortex. Brain research 20070716
Oxcarbazepine--efficacy and tolerability during treatment of alcohol withdrawal: a double-blind, randomized, placebo-controlled multicenter pilot study. Alcoholism, clinical and experimental research 20070701
Docosahexaenoic acid induces apoptosis in CYP2E1-containing HepG2 cells by activating the c-Jun N-terminal protein kinase related mitochondrial damage. The Journal of nutritional biochemistry 20070501
Altered benzodiazepine receptor sensitivity in alcoholism: a study with fMRI and acute lorazepam challenge. Psychiatry research 20070415
[Choice of sleeping pills to patients with Parkinson disease]. Lakartidningen 20070401
Measurement properties of the National Institutes of Health Stroke Scale for people with right- and left-hemisphere lesions: further analysis of the clomethiazole for acute stroke study-ischemic (class-I) trial. Archives of physical medicine and rehabilitation 20070301
Alcohol withdrawal syndrome: how to predict, prevent, diagnose and treat it. Prescrire international 20070201
Mitochondrial involvement in transhemispheric diaschisis following hypoxia-ischemia: Clomethiazole-mediated amelioration. Neuroscience 20070119
[Carbamazepine intoxication. Complication of alcohol detoxification with combined carbamazepine and tiapride]. Der Nervenarzt 20070101
Reduced baroreflex sensitivity in acute alcohol withdrawal syndrome and in abstained alcoholics. Drug and alcohol dependence 20061015
NXY-059: a hopeful sign in the treatment of stroke. Stroke 20061001
Heart rate variability and sympathetic skin response in male patients suffering from acute alcohol withdrawal syndrome. Alcoholism, clinical and experimental research 20060901
Ubiquitin-dependent degradation of p53 protein despite phosphorylation at its N terminus by acetaminophen. The Journal of pharmacology and experimental therapeutics 20060401
Modeling drug- and system-related changes in body temperature: application to clomethiazole-induced hypothermia, long-lasting tolerance development, and circadian rhythm in rats. The Journal of pharmacology and experimental therapeutics 20060401
Mallory body forming cells express the preneoplastic hepatocyte phenotype. Experimental and molecular pathology 20060401
Chorea induced by low-dose trazodone. European neurology 20060101
Driving under the influence of chlormethiazole. Forensic science international 20051029
Oxcarbazepine versus carbamazepine in the treatment of alcohol withdrawal. Addiction biology 20050901
Methodological quality of animal studies on neuroprotection in focal cerebral ischaemia. Journal of neurology 20050901
Effects of anticonvulsants on soman-induced epileptiform activity in the guinea-pig in vitro hippocampus. European journal of pharmacology 20050822
The effects of clomethiazole on polysomnographically recorded sleep in healthy subjects. European archives of psychiatry and clinical neuroscience 20050801
The role of laminin-integrin signaling in triggering MB formation. An in vivo and in vitro study. Experimental and molecular pathology 20050801
Induction of cytochrome P450 2E1 increases hepatotoxicity caused by Fas agonistic Jo2 antibody in mice. Hepatology (Baltimore, Md.) 20050801
Clomethiazole: mechanisms underlying lasting neuroprotection following hypoxia-ischemia. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20050601
The p105/50 NF-kappaB pathway is essential for Mallory body formation. Experimental and molecular pathology 20050601
CYP2E1 inhibition enhances mallory body formation. Experimental and molecular pathology 20050601
Effect of intravenous magnesium sulphate in reducing irritability and restlessness in pure and polysubstance opiate detoxification. Psychiatry research 20050515
Rapid and long-lasting tolerance to clomethiazole-induced hypothermia in the rat. European journal of pharmacology 20050411
Alcohol, vitamin A, and cancer. Alcohol (Fayetteville, N.Y.) 20050401
Treatment of alcohol withdrawal syndrome with combined carbamazepine and tiapride in a patient with probable sleep apnoe syndrome. Pharmacopsychiatry 20050301
Generic three-column parallel LC-MS/MS system for high-throughput in vitro screens. Journal of chromatography. A 20041126
Factor analysis of the National Institutes of Health Stroke Scale in patients with large strokes. Archives of neurology 20041101
Polysomnography during withdrawal with clomethiazole or placebo in alcohol dependent patients--a double-blind and randomized study. Pharmacopsychiatry 20040901
Chlormethiazole potentiates the discriminative stimulus effects of methamphetamine in rats. European journal of pharmacology 20040628
Clomethiazole alters immune function within an isolated cardiopulmonary bypass circuit. Anesthesia and analgesia 20040401
Treatment of alcohol withdrawal: chlormethiazole vs. carbamazepine and the effect on memory performance--a pilot study. Addiction biology 20040301
The proteasome inhibitor, PS-341, causes cytokeratin aggresome formation. Experimental and molecular pathology 20040201
Early impairment in consciousness predicts mortality after hemispheric ischemic stroke. Critical care medicine 20040101
Changes in fatalities due to overdose of anxiolytic and sedative drugs in the UK (1983-1999). Drug safety 20040101
The pharmacology of chlormethiazole: a potential neuroprotective agent? CNS drug reviews 20040101
Activity of chlormethiazole at human recombinant GABA(A) and NMDA receptors. British journal of pharmacology 20031101
Treatment of acute alcohol withdrawal with gabapentin: results from a controlled two-center trial. Journal of clinical psychopharmacology 20031001
Population pharmacokinetics of clomethiazole and its effect on the natural course of sedation in acute stroke patients. British journal of clinical pharmacology 20030801
Long-term effects of clomethiazole in a model of global ischemia. Experimental neurology 20030801
Diazepam and chlormethiazole attenuate the development of hyperthermia in an animal model of the serotonin syndrome. Neurochemistry international 20030701
The effect of clomethiazole on plasma concentrations of interleukin-6, -8, -1beta, tumor necrosis factor-alpha, and neutrophil adhesion molecule expression during experimental extracorporeal circulation. Anesthesia and analgesia 20030701
Pharmacokinetics and sedative effects in healthy subjects and subjects with impaired liver function after continuous infusion of clomethiazole. European journal of clinical pharmacology 20030601
Comparison of the neuroprotective effect of clomethiazole, AR-R15896AR and NXY-059 in a primate model of stroke using histological and behavioural measures. Brain research 20030516
Symptom-triggered versus standard chlormethiazole treatment of inpatient alcohol withdrawal: clinical implications from a chart analysis. European addiction research 20030101
Alcohol withdrawal treatment in intoxicated vs non-intoxicated patients: a controlled open-label study with tiapride/carbamazepine, clomethiazole and diazepam. Alcohol and alcoholism (Oxford, Oxfordshire) 20030101
Assessment of cognitive and motor deficits in a marmoset model of stroke. ILAR journal 20030101
The vitamin-E analog trolox and the NMDA antagonist MK-801 protect pyramidal neurons in hippocampal slice cultures from IL-1beta-induced neurodegeneration. Neurotoxicity research 20030101
The neuroprotective agents chlomethiazole and SB203580 inhibit IL-1beta signalling but not its biosynthesis in rat cortical glial cells. Journal of neurochemistry 20021101
Chlormethiazole treatment prevents reduced hepatic vitamin A levels in ethanol-fed rats. Alcoholism, clinical and experimental research 20021101
Electrophysiological actions of gamma-aminobutyric acid and clomethiazole on recombinant GABA(A) receptors. European journal of pharmacology 20021011
The role of the ubiquitin-proteasome pathway in the formation of mallory bodies. Experimental and molecular pathology 20021001
Clinical trial of the neuroprotectant clomethiazole in coronary artery bypass graft surgery: a randomized controlled trial. Anesthesiology 20020901
Serum concentration of chlormethiazole and therapeutic effect in acute alcohol withdrawal syndrome: an open clinical trial. Therapeutic drug monitoring 20020601
Gateways to clinical trials. Methods and findings in experimental and clinical pharmacology 20020501
Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells. The Journal of biological chemistry 20020419
[Delirium in old age can be prevented and treated]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20020320
[Diagnosis and treatment of delirium]. Praxis 20020313
Investigation of the effect of chlormethiazole on cerebral chemistry in neurosurgical patients: a combined study of microdialysis and a neuroprotective agent. British journal of clinical pharmacology 20020301
The Mallory body as an aggresome: in vitro studies. Experimental and molecular pathology 20020201
Neuroprotective agents in acute ischemic stroke. The Journal of the Association of Physicians of India 20020201
Clomethiazole Acute Stroke Study in ischemic stroke (CLASS-I): final results. Stroke 20020101
Clomethiazole: an unsuccessful bachelor, but perhaps a prosperous married man? Stroke 20020101
Double-blind controlled trial of gamma-hydroxybutyrate and clomethiazole in the treatment of alcohol withdrawal. Alcohol and alcoholism (Oxford, Oxfordshire) 20020101
GABA agonist: clomethiazole. Current medical research and opinion 20020101
A study of the mechanisms involved in the neurotoxic action of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') on dopamine neurones in mouse brain. British journal of pharmacology 20011201
The Clomethiazole Acute Stroke Study in tissue-type plasminogen activator-treated stroke (CLASS-T): final results. Neurology 20011009
Neuroprotective efficacy of AR-A008055, a clomethiazole analogue, in a global model of acute ischaemic stroke and its effect on ischaemia-induced glutamate and GABA efflux in vitro. Neuropharmacology 20010801
The interaction of AR-A008055 and its enantiomers with the GABA(A) receptor complex and their sedative, muscle relaxant and anticonvulsant activity. Neuropharmacology 20010801
Studies on the neuroprotective effect of the enantiomers of AR-A008055, a compound structurally related to clomethiazole, on MDMA ('ecstasy')-induced neurodegeneration in rat brain. Psychopharmacology 20010801
Treatment of alcohol withdrawal: tiapride and carbamazepine versus clomethiazole. A pilot study. European archives of psychiatry and clinical neuroscience 20010801
[Clomethiazole as an adjuvant in the treatment of confusional psychosis]. Fortschritte der Neurologie-Psychiatrie 20010601
Ethanol enhances retinoic acid metabolism into polar metabolites in rat liver via induction of cytochrome P4502E1. Gastroenterology 20010101
Current status and perspectives of neuroprotection in ischemic stroke treatment. Cerebrovascular diseases (Basel, Switzerland) 20010101
Chlormethiazole: effectiveness against toxic effects of cocaine in mice. The Journal of pharmacology and experimental therapeutics 20001001
Effect of starvation and chlormethiazole on cytochrome P450s of rat nasal mucosa. Biochemical pharmacology 20000601
The clomethiazole acute stroke study in ischemic, hemorrhagic, and t-PA treated stroke: Design of a phase III trial in the united states and canada. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 19980101
Inhibition of CYP2E1 activity does not abolish pulsatile urine alcohol concentrations during chronic alcohol infusions. European journal of biochemistry 19950615
Sudden death after intravenous application of lorazepam in a patient treated with clozapine. The American journal of psychiatry 19940501
Striatal dopamine release in vivo following neurotoxic doses of methamphetamine and effect of the neuroprotective drugs, chlormethiazole and dizocilpine. British journal of pharmacology 19930301
[Cholestatic hepatitis secondary to clomethiazole]. Medicina clinica 19920516
The neurotoxic effects of methamphetamine on 5-hydroxytryptamine and dopamine in brain: evidence for the protective effect of chlormethiazole. Neuropharmacology 19920401
A single-dose study of the pharmacodynamic effects of chlormethiazole, temazepam and placebo in elderly parkinsonian patients. Age and ageing 19911101
Focal dystonic reaction to phenytoin. Developmental medicine and child neurology 19841001
Anticonvulsant-induced status epilepticus in Lennox-Gastaut syndrome. Epilepsia 19810201
Alpha and beta coma in drug intoxication uncomplicated by cerebral hypoxia. Electroencephalography and clinical neurophysiology 19790101

© 2019 Angene International Limited. All rights Reserved.